Microdosing psilocybin improved depression, anxiety, and stress symptoms
Editor This observational study, published June 30 in Nature-Scientific Reports, included over 900 people who reported microdosing Psilocybin during…
Editor
Ruxolitinib cream, the first at-home therapy for Vitiligo, has been approved by the FDA.
The FDA approval is a development that is being cheered by many, but for Tonja Johnson, the founder…
COVID-19 infection could lead to loss of sense of smell and taste
In the study, published in the journal BMJ, researchers say that loss of smell may be long-lasting in…
The United States’ rural and urban areas might be rocked by a fresh wave of opioid overdoses, according to researchers
According to experts from Northwestern Medicine in Chicago who examined patterns and applied a predictive model to identify…
The CDC urges the general public to be cautious of the rare and fatal bacterial disease called Melioidosis
Though it is a serious illness, the risk to the general population remains low, the CDC added. A…
For those with type two Diabetes, limiting their meals to a 10-hour timeframe during the daytime may be advantageous
The authors of the new study note that in many Western countries, food is available 24 hours a…
A novel medication encourages the healing of the neurological system in animal models of Stroke
The groundbreaking preclinical study was written by researchers from Case Western Reserve University and UC, and it was…
Balding: Is it inevitable? Recent studies suggest not
New research from the University of California, Riverside suggests the cure for baldness resides in understanding just one…
Early antibiotic use can result in lifelong allergies and Asthma
The study, which was published in Mucosal Immunology, has offered the clearest proof to date that the long-recognized…
Certain kinds of stress might be advantageous for brain function
In a study that was published in Psychiatry Research, researchers discovered that low to moderate amounts of stress…
